Property-Based Drug Design

The drug discovery landscape is rapidly changing and with it comes the need to generate leads with lower attrition rate. Property-based drug design approach is guiding researchers in designing candidates with the right balance of physicochemical properties - safety and absorption, distribution, metabolism, and excretion (ADME) profiles. 4th Annual Property-Based Drug Design in Medicinal Chemistry conference will bring together experts and leaders from industry and academia to share strategies and case studies for new and non-traditional molecules, how computational modeling and data management can be used effectively, and to discuss novel ways to measure or predict properties to make molecules more drug-like and overcome challenges in discovery, development, and the clinic.

Preliminary Agenda | Speaker Biographies

PROPERTY-BASED STRUCTURE DESIGN CONSIDERATION FOR NEW & NON-TRADITIONAL MOLECULES

Keynote Presentation: Exploring Macrocycles for Drug Discovery: Novel Lead Series for Challenging Protein-Protein Interactions

Nick Terrett, Ph.D., CSO, Ensemble Therapeutics Corp.